- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.10. | Chugai buys 'Asia lag' firm Renalys for $98m upfront | ||
| 24.10. | AZ, Organon fall foul of UK's code on pharma promotion | ||
| 24.10. | Bayer's prostate cancer drug Nubeqa cleared for NHS use | ||
| 24.10. | ICER says US new drug launch prices have risen sharply | ||
| 24.10. | GSK's Blenrep's back in US, but with a narrower label | ||
| 23.10. | George's triple therapy for hypertension hits mark in stroke | ||
| 23.10. | Google claims quantum advance could speed up drug discovery | ||
| 23.10. | Moderna drops mRNA jab for CMV after phase 3 fail | ||
| 23.10. | Alector ditches GSK-partnered dementia drug and cuts staff | ||
| 22.10. | Alkermes bets $2.1bn on Avadel and its narcolepsy drug | ||
| 22.10. | Ipsen buys ImCheck, adding mid-stage leukaemia drug | ||
| 22.10. | Takeda builds in cancer with monster $11.4bn Innovent deal | ||
| 22.10. | UK start-up Procyon has pancreatic cancer test in its sights | ||
| 21.10. | Galapagos abandons cell therapy, putting 365 jobs at risk | ||
| 21.10. | Novo Nordisk's chairman quits amid Foundation row | ||
| 21.10. | GSK will file oral carbapenem for complicated UTIs this year | ||
| 20.10. | Joy as retinal implant restores sight in geographic atrophy | ||
| 20.10. | ESMO: Ivonescimab beats BeOne PD-1 in first-line lung cancer | ||
| 20.10. | ESMO: Datroway, Trodelvy lay claim to frontline TNBC therapy | ||
| 20.10. | ESMO: Clear air emerges between Roche SERD and its rivals | ||
| 20.10. | CHMP backs first drug for lung disease bronchiectasis | ||
| 20.10. | Amgen, AZ's Tezspire challenges Dupixent in nasal polyps | ||
| 17.10. | ESMO: Lilly reveals scale of survival win with Verzenio | ||
| 17.10. | Could endometriosis be diagnosed with a simple test? | ||
| 17.10. | ViiV's bimonthly HIV PrEP jab cleared for use by NHS |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .